Alterations in Monocyte CD16 in association with diabetes complications

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Min, Danqing ^a,b   Brooks, Belinda ^a,b   Wong, Jencia ^a,b   Salomon, Robert ^b   Bao, Wensheng ^b   Harrisberg, Brian ^a   Twigg, Stephen M ^a,b   Yue, Dennis K ^a,b   McLennan, Susan V ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIABETOGENESIS; DISEASE DURATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE COUNT; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INDUCTION; BLOOD; CHEMISTRY; DIABETES MELLITUS; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; BIOLOGICAL MARKERS; DIABETES COMPLICATIONS; FEMALE; GPI-LINKED PROTEINS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, IGG;

MLCS; MLOWN;

EID: 84872165940     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/649083     Document Type: Article

References (39)

1. DCCT, Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997 46 11 1829 1839
2. AUSO, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352 9131 837 853 2-s2.0-0032511583 10.1016/S0140-6736(98)07019-6 (Pubitemid 28416718)
3. Stitt A. W., Jenkins A. J., Cooper M. E., Advanced glycation end products and diabetic complications. Expert Opinion on Investigational Drugs 2002 11 9 1205 1223 2-s2.0-0036738046 10.1517/13543784.11.9.1205
4. Devaraj S., Glaser N., Griffen S., Wang-Polagruto J., Miguelino E., Jialal I., Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 2006 55 3 774 779 2-s2.0-33644756809 (Pubitemid 43343235)
5. Tesch G. H., Role of macrophages in complications of type 2 diabetes. Clinical and Experimental Pharmacology and Physiology 2007 34 10 1016 1019 (Pubitemid 47274561)
6. Min D., Lyons J. G., Bonner J., Twigg S. M., Yue D. K., McLennan S. V., Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy. American Journal of Physiology 2009 297 5 F1229 F1237 2-s2.0-70350704815 10.1152/ajprenal.00074.2009
7. McNeill E., Channon K. M., Greaves D. R., Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications. Clinical Science 2010 118 11 641 655 2-s2.0-77954080333 10.1042/CS20090488
8. Chiarelli F., Cipollone F., Mohn A., Marini M., Iezzi A., Fazia M., Tumini S., De Cesare D., Pomilio M., Pierdomenico S. D., Di Gioacchino M., Cuccurullo F., Mezzetti A., Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes. Diabetes Care 2002 25 10 1829 1834 2-s2.0-0036781581 10.2337/diacare.25.10.1829 (Pubitemid 41071095)
9. Williams M. D., Nadler J. L., Inflammatory mechanisms of diabetic complications. Current Diabetes Reports 2007 7 3 242 248 (Pubitemid 46951922)
10. Kaul K., Hodgkinson A., Tarr J. M., Kohner E. M., Chibber R., Is inflammation a common retinal-renal-nerve pathogenic link in diabetes? Current diabetes reviews 2010 6 5 294 303 2-s2.0-79551482327
11. Gordon S., Taylor P. R., Monocyte and macrophage heterogeneity. Nature Reviews Immunology 2005 5 12 953 964 2-s2.0-28544446111 10.1038/nri1733 (Pubitemid 41746764)
12. Geissmann F., Jung S., Littman D. R., Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003 19 1 71 82 2-s2.0-0037963473 10.1016/S1074-7613(03)00174-2 (Pubitemid 36859902)
13. Strauss-Ayali D., Conrad S. M., Mosser D. M., Monocyte subpopulations and their differentiation patterns during infection. Journal of Leukocyte Biology 2007 82 2 244 252 2-s2.0-34547730844 10.1189/jlb.0307191 (Pubitemid 47230633)
14. + blood monocytes: their role in infection and inflammation. Journal of Leukocyte Biology 2007 81 3 584 592 2-s2.0-33847789122 10.1189/jlb.0806510 (Pubitemid 46393535)
15. Auffray C., Sieweke M. H., Geissmann F., Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annual Review of Immunology 2009 27 669 692 2-s2.0-67649404131 10.1146/annurev.immunol.021908. 132557
16. Robbins C. S., Swirski F. K., The multiple roles of monocyte subsets in steady state and inflammation. Cellular and Molecular Life Sciences 2010 67 16 2685 2693 2-s2.0-77955713619 10.1007/s00018-010-0375-x
17. Weber C., Belge K. U., Von Hundelshausen P., Draude G., Steppich B., Mack M., Frankenberger M., Weber K. S. C., Ziegler-Heitbrock H. W. L., Differential chemokine receptor expression and function in human monocyte subpopulations. Journal of Leukocyte Biology 2000 67 5 699 704 2-s2.0-0033844802
18. Zimmermann H. W., Seidler S., Nattermann J., Gassler N., Hellerbrand C., Zernecke A., Tischendorf J. J., Luedde T., Weiskirchen R., Trautwein C., Tacke F., Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PloS one 2010 5 6 e11049 2-s2.0-77956215284 10.1371/journal.pone.0011049
19. Hauptmann S., Bernauer J., Zwadlo-Klarwasser G., Klosterhalfen B., Kirkpatrick C. J., Differential adherence of the human monocyte subsets 27E10 and RM3/1 to cytokine- or glucocorticoid treated endothelial cells. Pathobiology 1994 62 5-6 262 268 2-s2.0-0028645484
20. Betz P., Tubel J., Eisenmenger W., Immunohistochemical analysis of markers for different macrophage phenotypes and their use for a forensic wound age estimation. International Journal of Legal Medicine 1995 107 4 197 200 2-s2.0-0028911311 10.1007/BF01428405
21. Peters K. M., Koberg K., Rosendahl T., Klosterhalfen B., Straub A., Zwadlo-Klarwasser G., Macrophage reactions in septic arthritis. Archives of Orthopaedic and Trauma Surgery 1996 115 6 347 350 2-s2.0-0029818378 10.1007/BF00420330 (Pubitemid 26340676)
22. Holness C. L., Simmons D. L., Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993 81 6 1607 1613 2-s2.0-0027474061 (Pubitemid 23083842)
23. Lau S. K., Chu P. G., Weiss L. M., CD163: a specific marker of macrophages in paraffin-embedded tissue samples. American Journal of Clinical Pathology 2004 122 5 794 801 2-s2.0-7244238190 10.1309/QHD6-YFN8-1KQX-UUH6 (Pubitemid 39434761)
24. Seidler S., Zimmermann H. W., Bartneck M., Trautwein C., Tacke F., Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults. BMC Immunology 2010 11 article no. 30 2-s2.0-77953669656 10.1186/1471-2172-11-30
25. Frankenberger M., Sternsdorf T., Pechumer H., Pforte A., Ziegler-Heitbrock H. W. L., Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 1996 87 1 373 377 2-s2.0-0030034009 (Pubitemid 26011852)
26. Gonzalez Y., Herrera M. T., Soldevila G., Garcia-Garcia L., Fabian G., Perez-Armendariz E. M., Bobadilla K., Guzman-Beltran S., Sada E., Torres M., High glucose concentrations induce TNF-alpha production through the down-regulation of CD33 in primary human monocytes. BMC Immunology 2012 13 article no. 19
27. Tesch G. H., Macrophages and diabetic nephropathy. Seminars in Nephrology 2010 30 3 290 301 2-s2.0-77953877662 10.1016/j.semnephrol.2010.03.007
28. Apte R. S., Regulation of angiogenesis by macrophages. Advances in Experimental Medicine and Biology 2010 664 15 19
29. Ricardo S. D., Van Goor H., Eddy A. A., Macrophage diversity in renal injury and repair. Journal of Clinical Investigation 2008 118 11 3522 3530 2-s2.0-55849103960 10.1172/JCI36150
30. Corrales J. J., Almeida M., Burgo R. M., Hernández P., Miralles J. M., Orfao A., Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications. Journal of Diabetes and its Complications 2007 21 1 41 49 2-s2.0-33845616400 10.1016/j.jdiacomp.2005.09.006 (Pubitemid 44960839)
31. + monocytes producing TNF-alpha in complication-free diabetes type 1 juvenile onset patients. Cytokine 2012 60 1 309 317
32. Tuttle H. A., Davis-Gorman G., Goldman S., Copeland J. G., McDonagh P. F., Proinflammatory cytokines are increased in type 2 diabetic women with cardiovascular disease. Journal of Diabetes and its Complications 2004 18 6 343 351 2-s2.0-8644261645 10.1016/S1056-8727(03)00088-6 (Pubitemid 39505175)
33. Yan X. X., Lu L., Peng W. H., Wang L. J., Zhang Q., Zhang R. Y., Chen Q. J., Shen W. F., Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients. Atherosclerosis 2009 205 2 544 548 2-s2.0-67650234127 10.1016/j.atherosclerosis.2008.12.016
34. Taslipinar A., Yaman H., Yilmaz M. I., Demirbas S., Saglam M., Taslipinar M. Y., Agilli M., Kurt Y. G., Sonmez A., Azal O., Bolu E., Yenicesu M., Kutlu M., The relationship between inflammation, endothelial dysfunction and proteinuria in patients with diabetic nephropathy. Scandinavian Journal of Clinical & Laboratory 2011 71 7 606 612
35. Koleva-Georgieva D. N., Sivkova N. P., Terzieva D., Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy. Folia Medica 2011 53 2 44 50
36. Yuuki T., Kanda T., Kimura Y., Kotajima N., Tamura J., Kobayashi I., Kishi S., Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. Journal of Diabetes and its Complications 2001 15 5 257 259 2-s2.0-0034876205 10.1016/S1056-8727(01)00155-6 (Pubitemid 32750613)
37. Shimizu E., Funatsu H., Yamashita H., Yamashita T., Hori S., Plasma level of interleukin-6 is an indicator for predicting diabetic macular edema. Japanese Journal of Ophthalmology 2002 46 1 78 83 2-s2.0-0036184009 10.1016/S0021-5155(01)00452-X (Pubitemid 34195478)
38. + monocytes by exercise. American Journal of Physiology 2000 279 3 C578 C586 2-s2.0-0033830048
39. McGill M., Molyneaux L. M., Yue D. K., Turtle J. R., A single visit diabetes complication assessment service: a complement to diabetes management at the primary care level. Diabetic Medicine 1993 10 4 366 370 2-s2.0-0027229474 (Pubitemid 23134748)